Navigation Links
Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
Date:10/29/2009

Cash and cash equivalents, end of period $456,753 $632,959

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, the company's financial position, results of operations, market position, product development and business strategy, as well as estimates of future net sales, future expenses, future net income and future earnings per share. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "intend," "guidance" or similar expressions are forward-looking statements. Because these statements reflect our current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors could affect our future financial results and could cause our actual results to differ materially from those expressed in forward-looking statements contained in this press release. These factors include, but are not limited to: the possibility that the acquisition of Indevus is not complementary to Endo; the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory approval and commercialization of our products and pipeline products; competition in our industry, including for branded and generic products, and in connection with our acquisition of rights to assets, including intellectual property; government regulation of the pharmaceutical industry; our dependence on a small number of products and on outside manufacturers for the manufacture of our products; our dependence on third parties to supply raw materials and to provide services for certain core aspects of our business; new regulatory action or lawsuits relating to our use of controlled substances in many of our core products; our exposure to p
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
2. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
3. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
4. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
5. DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
6. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
7. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
8. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
9. Bellicum Pharmaceuticals Announces $4.5 Million in New Funding
10. BioMarin Acquires Huxley Pharmaceuticals, Inc.
11. Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... August 20, 2014 Glenmark ... Glenmark Pharmaceuticals Limited India (GPL), announces the discovery ... novel clinical development candidate, GBR 1302, a HER2xCD3 ... by the Glenmark Biologics Research Centre located in ... 1302 is based on Glenmark,s innovative BEAT antibody ...
(Date:8/19/2014)... Ala. , Aug. 19, 2014  The Alabama Supreme ... that patients can sue drug makers who mislead doctors into ... harmful side‑effects.  The case is Weeks v. Wyeth, and the ... makers in that same case last year. Heninger Garrison Davis ... represent the patient in the case, Danny Weeks . ...
(Date:8/19/2014)... , Aug. 19, 2014 Minimally Invasive ... medical device company, announced today that Mitsubishi Corporation ... and robotic visualization system in Japan ... sale in Japan in the ... also the exclusive distributor for Karl Storz GMBH & ...
Breaking Medicine Technology:Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 2Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4Minimally Invasive Devices and Mitsubishi Medical Japan Forge Exclusive Distribution Agreement 2
... 2011 Quest Diagnostics Incorporated (NYSE: DGX), the world,s ... today that Spark Acquisition Corporation, its wholly owned subsidiary ... outstanding shares of common stock of Celera Corporation (NASDAQ: ... has been extended to 5:00 p.m., New York City ...
... May 9, 2011 In honor of National ... launch and the grand opening of its home health and ... best in ecommerce and printed in-waiting room catalog solutions for ... those currently undergoing treatment and the 220,000 women who will ...
Cached Medicine Technology:Quest Diagnostics Announces Final Extension of Subsequent Offering Period for Shares of Celera 2Quest Diagnostics Announces Final Extension of Subsequent Offering Period for Shares of Celera 3Someone With Opens its Doors to Create Online Marketplace for Breast Cancer Products and Services 2Someone With Opens its Doors to Create Online Marketplace for Breast Cancer Products and Services 3Someone With Opens its Doors to Create Online Marketplace for Breast Cancer Products and Services 4
(Date:8/20/2014)... The Workgroup for Electronic Data ... the use of health IT to create efficiencies ... for its annual fall conference, WEDI-Con 2014: The ... will take place at the HYATT Regency in ... diverse cross-section of payers, providers, government regulators, industry ...
(Date:8/20/2014)... Fresh from the cradle of a world-class running city, an ... , Urbini, a new collection of versatile baby gear from ... jogger to its lineup. , The Avi has been in ... the latest racing styles and a set of features to ... a swift, smooth ride on runs, power-walks and causal strolls. ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 If old age ... a cure for it. With extensive research on HGH and ... ‘MetroMD’ claims to have perfected the art of rubbing off ... brand new younger look with their revolutionary anti-aging hormone therapy ... the 21st century fountain of youth, the MD of MetroMD, ...
(Date:8/20/2014)... NC (PRWEB) August 20, 2014 Doctors at ... way to wipe out mesothelioma in laboratory mice by injecting ... has just posted details of the study on its website. ... , Scientists with Hong Kong University’s AIDS Institute of Microbiology ... protein 1” or PD-1. By altering DNA, the vaccine is ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 The ... a five-year, $1.24 million Science Education Partnership Award ... to support NAHN’s collaborative project with the Hispanic ... Health Careers. , This collaborative NIH R25 program ... cultural and linguistic diversity among health professionals by ...
Breaking Medicine News(10 mins):Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 3Health News:Urbini Breezes Through Summer with New Jogging Stroller 2Health News:MetroMD Offers Revolutionary Anti-aging Hormone Therapy in Hollywood Area 2Health News:New Research Study Finds Vaccine Stops Mesothelioma in Lab Mice, According to Surviving Mesothelioma Website 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 3
... Office of Naval Research are working on using virtual ... Disorder (PTSD). //, ,In this research, scientists are ... from PTSD to go through the similar experiences they ... the traumatic experience that had left them unable to ...
... the declining numbers of infants in the Middle East ... first six months of their lives.//, ,"Several high-income ... Qatar, Oman, the UAE and Saudi Arabia maintain patterns ... below 35 percent," Unicef said in a statement released ...
... very active leisure time can reduce the chances of having ... from National Public Health Institute in Helsinki, Finland, had reported ... Heart Association., ,Researchers had looked into the data provided ... 25 to 64 years, all of them healthy and without ...
... the University of Arkansas, Worcester Polytechnic Institute //and other ... to examine the fossils of our ancestors’ teeth to ... and why. ,By comparing teeth from two species ... researchers confirm previous evidence that A. africanus ate more ...
... change in the genetic constitution is what makes each ... is unraveled, then health care can be individualized according ... same genetic code, how those genes express themselves at ... medicines and dietary advice. According to a recent study, ...
... Nebraska, was slated for a slow but sure death, weighing in ... or even turn over in bed. , ,Deuel is now ... than 200 kg after undergoing an operation that is becoming increasingly ... opera singer, Deborah Voigt, also lost 50 kg after she underwent ...
Cached Medicine News:Health News:Breastfeeding Decline In Middle East Worries UN 2Health News:Physical Activity During Leisure Can Reduce Risk Of Stroke 2Health News:Scientists Develop New Technology To Find About Human Ancestors’ Teet 2Health News:Learning Just How Different We Are 2Health News:Obesity better handled with gastric bypass surgery 2
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
... acetabular cup system has been designed to ... tri-spiked and cluster hole configurations. The objective ... micromotion on three primary modes: Tilt, migration ... features result in initial and long-term fixation. ...
The Biopro All Poly cup is a uniquely designed UHMWPE acetabular cup....
The Plasmacup SC satisfies two important requirements: high primary stability and a low friction bearing surface....
Medicine Products: